EnVVeno Medical Corporation EnVVeno Medical Corporation

EnVVeno Medical Corporation

NVNO

Clasificación en acciones #40242
enVVeno Medical Corporation, based in Irvine, California, is a medical device... enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from venous conditions. Their flagship product is the VenoValve, a specialized replacement venous valve developed for the management of chronic venous insufficiency. This device requires an open surgical procedure for implantation, which involves making a 5-to-6-inch incision in the patient's upper thigh to facilitate placement into the femoral vein. In addition to the VenoValve, enVVeno Medical is actively developing the enVVe system. This innovative system represents a non-surgical, transcatheter approach to venous valve replacement, comprising the enVVe valve itself, a dedicated delivery mechanism, and various supplementary accessories. The company previously operated under the name Hancock Jaffe Laboratories, Inc., before officially rebranding to enVVeno Medical Corporation in October 2021.
Precio por acción
$10.71
Última sincronización: 2026-07-31
Capitalización bursátil
$176.75K
Cambio (1 día)
0.79%
Cambio (1 año)
169,900.00%
País
US
Comercio EnVVeno Medical Corporation (NVNO)

Categoría

Healthcare
Historial de desdoblamientos de acciones de EnVVeno Medical Corporation (NVNO)
La acción EnVVeno Medical Corporation (símbolo: NVNO) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Oct 21, 2026.
Una acción NVNO comprada antes de Oct 21, 2026 equivaldría hoy a 0 acciones NVNO.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
9 x285
US
7 x127
IE
9 x162
US
2 x4
US
0 -
DE